home > drugs a-z list > totect (dexrazoxane for injection, intravenous infusion only) drug center > totect (dexrazoxane for injection, intravenous infusion only) drug - patient how to take

Totect

font size

Totect Patient Information including How Should I Take

What should I discuss with my health care provider before receiving dexrazoxane (Totect)?

You should not receive this medication if your chemotherapy does not include doxorubicin or a similar medication such as:

  • daunorubicin (Cerubidine);
  • epirubicin (Ellence);
  • idarubicin (Idamycin); or
  • mitoxantrone (Novantrone);

Before you receive dexrazoxane, tell your doctor if you are allergic to any drugs, or if you have kidney disease. You may need dose adjustments or special tests during treatment.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether dexrazoxane passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is dexrazoxane given (Totect)?

Dexrazoxane is given as an injection through a needle placed into a vein. You will receive this injection in a clinic or cancer treatment setting. Dexrazoxane is usually given 30 minutes before your dose of doxorubicin.

Dexrazoxane can add to the bone marrow lowering effects of chemotherapy. This can weaken your immune system, making it easier for you to get sick from being around others who are ill.

To be sure your blood cells do not get too low, your blood will need to be tested on a regular basis. Your kidney function may also need to be checked with urine tests. Do not miss any scheduled appointments.

Related Drug Centers

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.